Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
Phase 2 Completed
16 enrolled
Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Phase 2 Completed
37 enrolled 8 charts
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2 Completed
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
Phase 2 Completed
26 enrolled 10 charts
EPICentro
Phase 2 Completed
28 enrolled
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
Phase 2 Completed
22 enrolled
Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma
Phase 2 Completed
77 enrolled 15 charts
Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI
Phase 2 Completed
36 enrolled 13 charts
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
Phase 2 Completed
56 enrolled
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
Phase 2 Completed
60 enrolled
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
Phase 2 Completed
18 enrolled 8 charts
Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma
Phase 2 Completed
36 enrolled 14 charts
Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon
Phase 2 Completed
36 enrolled
Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma
Phase 2 Completed
57 enrolled 9 charts
Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer
Phase 2 Completed
28 enrolled
Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
Phase 2 Completed
19 enrolled
S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
93 enrolled
S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia
Phase 2 Completed
9 enrolled
Interferon Alfa in Treating Children With HIV-Related Cancer
Phase 2 Completed
8 enrolled
Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia
Phase 2 Completed
Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer
Phase 2 Completed
41 enrolled
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Phase 2 Completed
40 enrolled
Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer
Phase 2 Completed
Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma
Phase 2 Completed
Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Phase 2 Completed
30 enrolled
Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma
Phase 2 Completed
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
Phase 2 Completed
Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma
Phase 2 Completed
60 enrolled
Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Phase 2 Completed
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia
Phase 2 Completed
Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors
Phase 2 Completed
Chemotherapy and Radiation Following Pancreatic Surgery
Phase 2 Completed
53 enrolled
Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma
Phase 2 Completed
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Phase 2 Completed
40 enrolled
Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Phase 2 Completed
87 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
Phase 2 Completed
75 enrolled
BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
Phase 2 Completed
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
Phase 2 Completed
20 enrolled
Bone Marrow Transplantation in Treating Patients With Lymphoma
Phase 2 Completed
45 enrolled
Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Phase 2 Completed
90 enrolled
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
Phase 2 Completed
90 enrolled
Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
Phase 2 Completed
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
Phase 2 Completed
29 enrolled 5 charts
Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma
Phase 2 Completed
Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia
Phase 2 Completed
40 enrolled
Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
Phase 2 Completed
SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
Phase 2 Completed
Treatment of Oral Warts in HIV+ Patients
Phase 2 Completed
59 enrolled 13 charts
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
Phase 2 Completed
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Phase 2 Completed